Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 129

1.

Coexistence of schwannomatosis and glioblastoma in two families.

Deiller C, Van-Gils J, Zordan C, Tinat J, Loiseau H, Fabre T, Delleci C, Cohen J, Vidaud M, Parfait B, Goizet C.

Eur J Med Genet. 2019 May 22:103680. doi: 10.1016/j.ejmg.2019.103680. [Epub ahead of print]

PMID:
31128261
2.

Responses in multiple myeloma should be assigned according to serum, not urine, free light chain measurements.

Dejoie T, Corre J, Caillon H, Moreau P, Attal M, Loiseau HA.

Leukemia. 2019 Feb;33(2):313-318. doi: 10.1038/s41375-018-0339-y. Epub 2018 Dec 20. Review.

3.

The molecular landscape of glioma in patients with Neurofibromatosis 1.

D'Angelo F, Ceccarelli M, Tala, Garofano L, Zhang J, Frattini V, Caruso FP, Lewis G, Alfaro KD, Bauchet L, Berzero G, Cachia D, Cangiano M, Capelle L, de Groot J, DiMeco F, Ducray F, Farah W, Finocchiaro G, Goutagny S, Kamiya-Matsuoka C, Lavarino C, Loiseau H, Lorgis V, Marras CE, McCutcheon I, Nam DH, Ronchi S, Saletti V, Seizeur R, Slopis J, Suñol M, Vandenbos F, Varlet P, Vidaud D, Watts C, Tabar V, Reuss DE, Kim SK, Meyronet D, Mokhtari K, Salvador H, Bhat KP, Eoli M, Sanson M, Lasorella A, Iavarone A.

Nat Med. 2019 Jan;25(1):176-187. doi: 10.1038/s41591-018-0263-8. Epub 2018 Dec 10.

PMID:
30531922
4.

Pomalidomide, cyclophosphamide, and dexamethasone for relapsed multiple myeloma.

Garderet L, Kuhnowski F, Berge B, Roussel M, Escoffre-Barbe M, Lafon I, Facon T, Leleu X, Karlin L, Perrot A, Moreau P, Marit G, Stoppa AM, Royer B, Chaleteix C, Tiab M, Araujo C, Lenain P, Macro M, Voog E, Benboubker L, Allangba O, Jourdan E, Orsini-Piocelle F, Brechignac S, Eveillard JR, Belhadj K, Wetterwald M, Pegourie B, Jaccard A, Eisenmann JC, Glaisner S, Mohty M, Hulin C, Loiseau HA, Mathiot C, Attal M.

Blood. 2018 Dec 13;132(24):2555-2563. doi: 10.1182/blood-2018-07-863829. Epub 2018 Oct 3.

PMID:
30282798
5.

Increasing incidence of central nervous system (CNS) tumors (2000-2012): findings from a population based registry in Gironde (France).

Pouchieu C, Gruber A, Berteaud E, Ménégon P, Monteil P, Huchet A, Vignes JR, Vital A, Loiseau H, Baldi I.

BMC Cancer. 2018 Jun 14;18(1):653. doi: 10.1186/s12885-018-4545-9.

6.

Contralateral Transcranial Approach to Tuberculum Sellae Meningiomas: Long-Term Visual Outcomes and Recurrence Rates.

Engelhardt J, Namaki H, Mollier O, Monteil P, Penchet G, Cuny E, Loiseau H.

World Neurosurg. 2018 Aug;116:e1066-e1074. doi: 10.1016/j.wneu.2018.05.166. Epub 2018 Jun 1.

PMID:
29864568
7.

Allergic conditions and risk of glioma and meningioma in the CERENAT case-control study.

Pouchieu C, Raherison C, Piel C, Migault L, Carles C, Fabbro-Perray P, Loiseau H, Guillamo JS, Lebailly P, Baldi I.

J Neurooncol. 2018 Jun;138(2):271-281. doi: 10.1007/s11060-018-2816-6. Epub 2018 Mar 2.

PMID:
29500663
8.

De novo and secondary anaplastic meningiomas: a study of clinical and histomolecular prognostic factors.

Peyre M, Gauchotte G, Giry M, Froehlich S, Pallud J, Graillon T, Bielle F, Cazals-Hatem D, Varlet P, Figarella-Branger D, Loiseau H, Kalamarides M.

Neuro Oncol. 2018 Jul 5;20(8):1113-1121. doi: 10.1093/neuonc/nox231.

PMID:
29216385
9.

Progestin-associated shift of meningioma mutational landscape.

Peyre M, Gaillard S, de Marcellus C, Giry M, Bielle F, Villa C, Boch AL, Loiseau H, Baussart B, Cazabat L, Raffin-Sanson ML, Sanson M, Kalamarides M.

Ann Oncol. 2018 Mar 1;29(3):681-686. doi: 10.1093/annonc/mdx763.

PMID:
29206892
10.

DKK1 and sclerostin are early markers of relapse in multiple myeloma.

Mabille C, Ruyssen-Witrand A, Degboe Y, Gennero I, Loiseau HA, Roussel M, Hebraud B, Nigon D, Attal M, Laroche M.

Bone. 2018 Aug;113:114-117. doi: 10.1016/j.bone.2017.10.004. Epub 2017 Oct 6.

PMID:
28993177
11.

Diffuse midline skull base meningiomas: identification of a rare and aggressive subgroup of meningiomas.

Peyre M, Feuvret L, Sanson M, Navarro S, Boch AL, Loiseau H, Kalamarides M.

J Neurooncol. 2017 Jul;133(3):633-639. doi: 10.1007/s11060-017-2480-2. Epub 2017 May 23.

PMID:
28536991
12.

[Adult intramedullary gliomas].

Campello C, Parker F, Slimani S, Le Floch A, Herbrecht A, Aghakhani N, Lacroix C, Loiseau H, Lejeune JP, Perrin G, Honnorat J, Dufour H, Chinot O, Figarella D, Bauchet L, Duffau H, Lonjon M, Labauge P, Messerer M, Daures JP, Fabbro P, Ducot B.

Neurochirurgie. 2017 Nov;63(5):381-390. doi: 10.1016/j.neuchi.2016.10.003. Epub 2017 May 18. French.

PMID:
28527519
13.

Natural course and prognosis of anaplastic gangliogliomas: a multicenter retrospective study of 43 cases from the French Brain Tumor Database.

Terrier LM, Bauchet L, Rigau V, Amelot A, Zouaoui S, Filipiak I, Caille A, Almairac F, Aubriot-Lorton MH, Bergemer-Fouquet AM, Bord E, Cornu P, Czorny A, Dam Hieu P, Debono B, Delisle MB, Emery E, Farah W, Gauchotte G, Godfraind C, Guyotat J, Irthum B, Janot K, Le Reste PJ, Liguoro D, Loiseau H, Lot G, Lubrano V, Mandonnet E, Menei P, Metellus P, Milin S, Muckenstrum B, Roche PH, Rousseau A, Uro-Coste E, Vital A, Voirin J, Wager M, Zanello M, François P, Velut S, Varlet P, Figarella-Branger D, Pallud J, Zemmoura I; Club de Neuro-Oncologie of the Société Française de Neurochirurgie.

Neuro Oncol. 2017 May 1;19(5):678-688. doi: 10.1093/neuonc/now186.

14.

[The GLITRAD (Adult Brainstem Gliomas) network: A national multidisciplinary group dedicated to brainstem gliomas in adults].

Laigle-Donadey F, Loiseau H; au nom du groupe GLITRAD du réseau TUCERA de l’ANOCEF.

Bull Cancer. 2017 Jun;104(6):593-595. doi: 10.1016/j.bulcan.2017.03.007. Epub 2017 Apr 17. French. No abstract available.

PMID:
28427714
15.

Dietary and Alcohol Intake and Central Nervous System Tumors in Adults: Results of the CERENAT Multicenter Case-Control Study.

Allès B, Pouchieu C, Gruber A, Lebailly P, Loiseau H, Fabbro-Peray P, Letenneur L, Baldi I.

Neuroepidemiology. 2016;47(3-4):145-154. doi: 10.1159/000450580. Epub 2016 Nov 26.

PMID:
27889752
16.

[Adolescent and Young Adults (AYAS) brain tumor national Web conference. On behalf of ANOCEF, GO-AJA and SFCE societies].

Frappaz D, Sunyach MP, Le Rhun E, Blonski M, Laurence V, Bonneville Levard A, Loiseau H, Meyronnet D, Callies A, Laigle-Donadey F, Faure Conter C; au nom de l’ANOCEF, GO-AJA, de la SFCE.

Bull Cancer. 2016 Dec;103(12):1050-1056. doi: 10.1016/j.bulcan.2016.10.010. Epub 2016 Nov 17. French.

PMID:
27866682
17.

In Vivo Follow-up of Brain Tumor Growth via Bioluminescence Imaging and Fluorescence Tomography.

Genevois C, Loiseau H, Couillaud F.

Int J Mol Sci. 2016 Oct 31;17(11). pii: E1815.

18.

Prognostic impact of the 2016 WHO classification of diffuse gliomas in the French POLA cohort.

Tabouret E, Nguyen AT, Dehais C, Carpentier C, Ducray F, Idbaih A, Mokhtari K, Jouvet A, Uro-Coste E, Colin C, Chinot O, Loiseau H, Moyal E, Maurage CA, Polivka M, Lechapt-Zalcman E, Desenclos C, Meyronet D, Delattre JY, Figarella-Branger D; For POLA Network.

Acta Neuropathol. 2016 Oct;132(4):625-34. doi: 10.1007/s00401-016-1611-8. Epub 2016 Aug 29.

PMID:
27573687
19.

Characteristics of gliomas in patients with somatic IDH mosaicism.

Bonnet C, Thomas L, Psimaras D, Bielle F, Vauléon E, Loiseau H, Cartalat-Carel S, Meyronet D, Dehais C, Honnorat J, Sanson M, Ducray F.

Acta Neuropathol Commun. 2016 Mar 31;4:31. doi: 10.1186/s40478-016-0302-y.

20.

Descriptive epidemiology and risk factors of primary central nervous system tumors: Current knowledge.

Pouchieu C, Baldi I, Gruber A, Berteaud E, Carles C, Loiseau H.

Rev Neurol (Paris). 2016 Jan;172(1):46-55. doi: 10.1016/j.neurol.2015.10.007. Epub 2015 Dec 23. Review.

PMID:
26708326
21.

Combining Cadherin Expression with Molecular Markers Discriminates Invasiveness in Growth Hormone and Prolactin Pituitary Adenomas.

Chauvet N, Romanò N, Meunier AC, Galibert E, Fontanaud P, Mathieu MN, Osterstock G, Osterstock P, Baccino E, Rigau V, Loiseau H, Bouillot-Eimer S, Barlier A, Mollard P, Coutry N.

J Neuroendocrinol. 2016 Feb;28(2):12352. doi: 10.1111/jne.12352.

PMID:
26686489
22.

Allelic loss of 9p21.3 is a prognostic factor in 1p/19q codeleted anaplastic gliomas.

Alentorn A, Dehais C, Ducray F, Carpentier C, Mokhtari K, Figarella-Branger D, Chinot O, Cohen-Moyal E, Ramirez C, Loiseau H, Elouahdani-Hamdi S, Beauchesne P, Langlois O, Desenclos C, Guillamo JS, Dam-Hieu P, Ghiringhelli F, Colin P, Godard J, Parker F, Dhermain F, Carpentier AF, Frenel JS, Menei P, Bauchet L, Faillot T, Fesneau M, Fontaine D, Motuo-Fotso MJ, Vauleon E, Gaultier C, Le Guerinel C, Gueye EM, Noel G, Desse N, Durando X, Barrascout E, Wager M, Ricard D, Carpiuc I, Delattre JY, Idbaih A; POLA Network.

Neurology. 2015 Oct 13;85(15):1325-31. doi: 10.1212/WNL.0000000000002014. Epub 2015 Sep 18.

23.

MB4-2 breakpoint in MMSET combined with del(17p) defines a subset of t(4;14) multiple myeloma with very poor prognosis.

Lazareth A, Song XY, Coquin A, Harel S, Karlin L, Belhadj K, Roos-Weil D, Frenzel L, Tamburini J, Macro M, Chevret S, Loiseau HA, Minvielle S, Fermand JP, Soulier J, Bories JC, Arnulf B.

Haematologica. 2015 Nov;100(11):e471-4. doi: 10.3324/haematol.2015.127001. Epub 2015 Jul 23. No abstract available.

24.

Descriptive epidemiology of 13,038 newly diagnosed and histologically confirmed meningiomas in France: 2006-2010.

Zouaoui S, Darlix A, Rigau V, Mathieu-Daudé H, Bauchet F, Bessaoud F, Fabbro-Peray P, Trétarre B, Figarella-Branger D, Taillandier L, Loiseau H, Bauchet L; French Brain Tumor DataBase (FBTDB) Participants and Investigators; with the participation of the Société française de neurochirurgie (SFNC); Club de neuro-oncologie de la SFNC; Société française de neuropathologie (SFNP); Association des neuro-oncologues d’expression française (ANOCEF).

Neurochirurgie. 2018 Mar;64(1):15-21. doi: 10.1016/j.neuchi.2014.11.013.

PMID:
26073920
25.

[Surgery of brain metastases].

Métellus P, Reyns N, Voirin J, Menei P, Bauchet L, Faillot T, Loiseau H, Pallud J, Guyotat J, Mandonnet E.

Cancer Radiother. 2015 Feb;19(1):20-4. doi: 10.1016/j.canrad.2014.11.007. Epub 2015 Jan 29. Review. French.

PMID:
25640217
26.

Epidemiology of meningiomas.

Baldi I, Engelhardt J, Bonnet C, Bauchet L, Berteaud E, Grüber A, Loiseau H.

Neurochirurgie. 2018 Mar;64(1):5-14. doi: 10.1016/j.neuchi.2014.05.006. Epub 2014 Sep 22. Review.

PMID:
25249493
27.

Intravertebral pseudomeningocele: an unusual complication after disc surgery.

Buy X, Alberti N, Pointillart V, Loiseau H, Palussière J.

Spine J. 2014 Nov 1;14(11):e1-4. doi: 10.1016/j.spinee.2014.08.011. Epub 2014 Aug 19.

PMID:
25150142
28.

Accuracy of repeated measurements of late-night salivary cortisol to screen for early-stage recurrence of Cushing's disease following pituitary surgery.

Danet-Lamasou M, Asselineau J, Perez P, Vivot A, Nunes ML, Loiseau H, San-Galli F, Cherifi-Gatta B, Corcuff JB, Tabarin A.

Clin Endocrinol (Oxf). 2015 Feb;82(2):260-6. doi: 10.1111/cen.12534. Epub 2014 Jul 25.

PMID:
24975391
29.

Mobile phone use and brain tumours in the CERENAT case-control study.

Coureau G, Bouvier G, Lebailly P, Fabbro-Peray P, Gruber A, Leffondre K, Guillamo JS, Loiseau H, Mathoulin-Pélissier S, Salamon R, Baldi I.

Occup Environ Med. 2014 Jul;71(7):514-22. doi: 10.1136/oemed-2013-101754. Epub 2014 May 9.

PMID:
24816517
30.

French research infrastructures to develop and validate glioma biomarkers.

Menei P, Figarella-Branger D, Bauchet L, Loiseau H, Denyset M, Roman T, Dehais C, Delattre JY.

Neurosurgery. 2014 Aug;75(2):E195-6. doi: 10.1227/NEU.0000000000000364. No abstract available.

PMID:
24739367
31.

Partial Response at Completion of Bortezomib-Thalidomide-Dexamethasone (VTd) Induction Regimen Upfront in Multiple Myeloma Does Not Preclude Response to VTd in Consolidation.

Fouquet G, Hebraud B, Garciaz S, Stoppa AM, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Touzeau C, Tessoulin B, Fermand JP, Facon T, Attal M, Loiseau HA, Moreau P, Leleu X.

J Cancer. 2014 Mar 11;5(3):248-52. doi: 10.7150/jca.8541. eCollection 2014.

32.

Oncological patterns of care and outcomes for 265 elderly patients with newly diagnosed glioblastoma in France.

Zouaoui S, Darlix A, Fabbro-Peray P, Mathieu-Daudé H, Rigau V, Fabbro M, Bessaoud F, Taillandier L, Ducray F, Bauchet F, Wager M, Faillot T, Capelle L, Loiseau H, Kerr C, Menei P, Duffau H, Figarella-Branger D, Chinot O, Trétarre B, Bauchet L.

Neurosurg Rev. 2014 Jul;37(3):415-23; discussion 423-4. doi: 10.1007/s10143-014-0528-8. Epub 2014 Feb 14.

PMID:
24526367
33.

Contrast enhancement in 1p/19q-codeleted anaplastic oligodendrogliomas is associated with 9p loss, genomic instability, and angiogenic gene expression.

Reyes-Botero G, Dehais C, Idbaih A, Martin-Duverneuil N, Lahutte M, Carpentier C, Letouzé E, Chinot O, Loiseau H, Honnorat J, Ramirez C, Moyal E, Figarella-Branger D, Ducray F; POLA Network.

Neuro Oncol. 2014 May;16(5):662-70. doi: 10.1093/neuonc/not235. Epub 2013 Dec 18.

34.

Posttranscriptional regulation of PER1 underlies the oncogenic function of IREα.

Pluquet O, Dejeans N, Bouchecareilh M, Lhomond S, Pineau R, Higa A, Delugin M, Combe C, Loriot S, Cubel G, Dugot-Senant N, Vital A, Loiseau H, Gosline SJ, Taouji S, Hallett M, Sarkaria JN, Anderson K, Wu W, Rodriguez FJ, Rosenbaum J, Saltel F, Fernandez-Zapico ME, Chevet E.

Cancer Res. 2013 Aug 1;73(15):4732-43. doi: 10.1158/0008-5472.CAN-12-3989. Epub 2013 Jun 10.

35.

Brain metastases from thyroid carcinoma: a retrospective study of 21 patients.

Henriques de Figueiredo B, Godbert Y, Soubeyran I, Carrat X, Lagarde P, Cazeau AL, Italiano A, Sargos P, Kantor G, Loiseau H, Bonichon F.

Thyroid. 2014 Feb;24(2):270-6. doi: 10.1089/thy.2013.0061. Epub 2013 Sep 11.

PMID:
23734630
36.

Consolidation with VTd significantly improves the complete remission rate and time to progression following VTd induction and single autologous stem cell transplantation in multiple myeloma.

Leleu X, Fouquet G, Hebraud B, Roussel M, Caillot D, Chrétien ML, Arnulf B, Szalat R, Garderet L, Benajiba L, Pegourie B, Regny C, Royer B, Caulier A, Stoppa AM, Garciaz S, Touzeau C, Chaleteix C, Fermand JP, Loiseau HA, Facon T, Attal M, Moreau P; Intergroupe Francophone du Myélome (IFM).

Leukemia. 2013 Nov;27(11):2242-4. doi: 10.1038/leu.2013.101. Epub 2013 Apr 5. No abstract available.

PMID:
23558525
37.

A new prognostic clinicopathological classification of pituitary adenomas: a multicentric case-control study of 410 patients with 8 years post-operative follow-up.

Trouillas J, Roy P, Sturm N, Dantony E, Cortet-Rudelli C, Viennet G, Bonneville JF, Assaker R, Auger C, Brue T, Cornelius A, Dufour H, Jouanneau E, François P, Galland F, Mougel F, Chapuis F, Villeneuve L, Maurage CA, Figarella-Branger D, Raverot G; members of HYPOPRONOS, Barlier A, Bernier M, Bonnet F, Borson-Chazot F, Brassier G, Caulet-Maugendre S, Chabre O, Chanson P, Cottier JF, Delemer B, Delgrange E, Di Tommaso L, Eimer S, Gaillard S, Jan M, Girard JJ, Lapras V, Loiseau H, Passagia JG, Patey M, Penfornis A, Poirier JY, Perrin G, Tabarin A.

Acta Neuropathol. 2013 Jul;126(1):123-35. doi: 10.1007/s00401-013-1084-y. Epub 2013 Feb 12.

PMID:
23400299
38.

(99m)Tc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9.

Da Rocha Gomes S, Miguel J, Azéma L, Eimer S, Ries C, Dausse E, Loiseau H, Allard M, Toulmé JJ.

Bioconjug Chem. 2012 Nov 21;23(11):2192-200. doi: 10.1021/bc300146c. Epub 2012 Nov 1.

PMID:
23043415
39.

[Performance evaluation of hospital claims database for the identification of incident central nervous system tumors compared with a cancer registry in Gironde, France, 2004].

Coureau G, Baldi I, Savès M, Jaffré A, Barat C, Gruber A, Loiseau H, Kostrzewa A, Servas V, Salamon R, Gilleron V.

Rev Epidemiol Sante Publique. 2012 Aug;60(4):295-304. doi: 10.1016/j.respe.2012.02.003. Epub 2012 Jun 15. French.

PMID:
22704681
40.

Descriptive epidemiology of CNS tumors in France: results from the Gironde Registry for the period 2000-2007.

Baldi I, Gruber A, Alioum A, Berteaud E, Lebailly P, Huchet A, Tourdias T, Kantor G, Maire JP, Vital A, Loiseau H; Gironde TSNC Registry Group.

Neuro Oncol. 2011 Dec;13(12):1370-8. doi: 10.1093/neuonc/nor120. Epub 2011 Oct 6.

41.

S100-B protein as a screening tool for the early assessment of minor head injury.

Zongo D, Ribéreau-Gayon R, Masson F, Laborey M, Contrand B, Salmi LR, Montaudon D, Beaudeux JL, Meurin A, Dousset V, Loiseau H, Lagarde E.

Ann Emerg Med. 2012 Mar;59(3):209-18. doi: 10.1016/j.annemergmed.2011.07.027. Epub 2011 Sep 23.

PMID:
21944878
42.

Occupational and residential exposure to electromagnetic fields and risk of brain tumors in adults: a case-control study in Gironde, France.

Baldi I, Coureau G, Jaffré A, Gruber A, Ducamp S, Provost D, Lebailly P, Vital A, Loiseau H, Salamon R.

Int J Cancer. 2011 Sep 15;129(6):1477-84. doi: 10.1002/ijc.25765. Epub 2011 Jan 12.

43.

Autophagy inhibition cooperates with erlotinib to induce glioblastoma cell death.

Eimer S, Belaud-Rotureau MA, Airiau K, Jeanneteau M, Laharanne E, Véron N, Vital A, Loiseau H, Merlio JP, Belloc F.

Cancer Biol Ther. 2011 Jun 15;11(12):1017-27. Epub 2011 Jun 15.

PMID:
21508666
44.

Brain tumors and hormonal factors: review of the epidemiological literature.

Cowppli-Bony A, Bouvier G, Rué M, Loiseau H, Vital A, Lebailly P, Fabbro-Peray P, Baldi I.

Cancer Causes Control. 2011 May;22(5):697-714. doi: 10.1007/s10552-011-9742-7. Epub 2011 Feb 26. Review.

PMID:
21359526
45.

Differentiation between normal and tumor vasculature of animal and human glioma by FTIR imaging.

Wehbe K, Pineau R, Eimer S, Vital A, Loiseau H, Déléris G.

Analyst. 2010 Dec;135(12):3052-9. doi: 10.1039/c0an00513d. Epub 2010 Oct 7.

PMID:
20927459
46.

[Epidemiology of glioblastoma].

Baldi I, Huchet A, Bauchet L, Loiseau H.

Neurochirurgie. 2010 Dec;56(6):433-40. doi: 10.1016/j.neuchi.2010.07.011. Epub 2010 Sep 24. French.

PMID:
20869733
47.

[Normal tissue tolerance to external beam radiation therapy: peripheral nerves].

Henriques de Figueiredo B, Huchet A, Dejean C, Mamou N, Sargos P, Loiseau H, Kantor G.

Cancer Radiother. 2010 Jul;14(4-5):405-10. doi: 10.1016/j.canrad.2010.03.012. Epub 2010 Jun 30. French.

PMID:
20580590
48.

Biodegradable carmustine wafers (Gliadel) alone or in combination with chemoradiotherapy: the French experience.

Menei P, Metellus P, Parot-Schinkel E, Loiseau H, Capelle L, Jacquet G, Guyotat J; Neuro-oncology Club of the French Society of Neurosurgery.

Ann Surg Oncol. 2010 Jul;17(7):1740-6. doi: 10.1245/s10434-010-1081-5. Epub 2010 May 5.

PMID:
20443147
49.

A 61-year-old man with instability of gait and right hand clumsiness.

Vital A, Ellie E, Loiseau H.

Brain Pathol. 2010 Jan;20(1):273-4. doi: 10.1111/j.1750-3639.2009.00349.x.

PMID:
20438489
50.

Oncological patterns of care and outcome for 952 patients with newly diagnosed glioblastoma in 2004.

Bauchet L, Mathieu-Daudé H, Fabbro-Peray P, Rigau V, Fabbro M, Chinot O, Pallusseau L, Carnin C, Lainé K, Schlama A, Thiebaut A, Patru MC, Bauchet F, Lionnet M, Wager M, Faillot T, Taillandier L, Figarella-Branger D, Capelle L, Loiseau H, Frappaz D, Campello C, Kerr C, Duffau H, Reme-Saumon M, Trétarre B, Daures JP, Henin D, Labrousse F, Menei P, Honnorat J; Société Française de Neurochirurgie (SFNC); Club de Neuro-Oncologie of the Société Française de Neurochirurgie (CNO-SFNC); Société Française de Neuropathologie (SFNP); Association des Neuro-Oncologues d'Expression Française (ANOCEF).

Neuro Oncol. 2010 Jul;12(7):725-35. doi: 10.1093/neuonc/noq030. Epub 2010 Apr 2.

Supplemental Content

Loading ...
Support Center